Document is current
Any future updates will be listed below
-
Authors
Chiba, Yohei
Sudo, Kazuki
Kojima, Yuki
Okuma, Hitomi
Kohsaka, Shinji
Machida, Ryunosuke
Ichimura, Masahiko
Anjo, Kenta
Kurishita, Kazumi
Okita, Natsuko
Nakamura, Kenichi
Kinoshita, Ichiro
Takahashi, Masanobu
Matsubara, Junichi
Kusaba, Hitoshi
Yonemori, Kan
Takahashi, Masamichi https://orcid.org/0000-0001-8792-1993
-
Funding
Funding for this research was provided by:
Japan Agency for MedicalResearch and Development (20lk1403036h0001)
Eisai (A2020-242 (N2006))
- License Information
-
More Information
Article History
Received: 10 June 2022
Accepted: 29 July 2022
First Online: 9 August 2022
Declarations
:
: The National Cancer Center Hospital Certified Review Board approved the study protocol in March 2021, and participant enrollment began in June 2021 (Institutional review board registry number: T4912). This study was also approved by the Ethics Committees of Hokkaido University Hospital (R3-1), Tohoku University Hospital (213004), Kyoto University Hospital (K078), and Kyushu University Hospital (2021302). All participants receive written and oral information prior to participation and provide written and verbal consent.
: This manuscript contains no individual person’s data.
: This study is supported by Eisai Co., Ltd. and AMED (Japan Agency for Medical Research and Development) under the grant number 20lk1403036h0001. All authors declare that they have no competing interests on this study.
